ISOPP: Call for Newsletter Articles and Members for Two New Task Forces

The International Society of Oncology Pharmacy Practitioners (ISOPP) exists to advance oncology pharmacy care for patients around the world and we are seeking volunteers for the following activities. Join your peers and make a difference by either writing an article and/or joining two new recently formed Task Forces. 

 

1. Article for ISOPP’s June Newsletter: 

Contribute an article to be published in ISOPP’s next quarterly ISOPP Newsletter The deadline is Monday, June 15 (let us know if you need more time). 

Suggested topics are:

  • A ‘Day in the Life of a <name country> oncology pharmacist during the COVID19 outbreak, 
  • Key takeaways from a conference (virtual or in person) you may have attended recently, or
  • Anything else you would like to share with ISOPP members in oncology pharmacy and your practice.

Submit your article to Evelyn Handel, Newsletter Editor at newsletter@isopp.org by Monday, June 15. 

ISOPP’s Newsletter, published quarterly and sent via email directly to members, is the home of international discussion on oncology pharmacy research and practice and ISOPP news and business. We are always looking for contributions.   
 

2. Call for members to join the Member Engagement Task Force and/or the Immunotherapy Task Force:

The Secretariat is forming two Task Forces, one to develop an ISOPP position paper on the role of the oncology pharmacist in the era of immunotherapy, and the other to propose strategies to increase member engagement and membership numbers, and to make recommendations on ways to reward active members formally.
 

Please email services@isopp.org by Monday, June 15 to express your interest in being part of these Task Forces. Thank you to those who have already responded. 

If you would like further information on these initiatives, please contact either, Shaun O’Connor, President at president@isopp.org or Alex Chan, Past President at pastpresident@isopp.org.  

Thank you for considering the above opportunities and for being a part of the oncology pharmacy global community advancing cancer care. We look forward to receiving your articles.

 

 
Tags: